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Objectives: Current worldwide spread of carbapenem resistance in Enterobacteriaceae
constitutes a critical public health threat. This study aims to investigate how carbapenem
resistance is acquired in Enterobacteriaceae in patients during antimicrobial therapy.
Methods: Clinical strains from the same anatomical site of the same patients that
converted from carbapenem-susceptible to resistant during antimicrobial therapy and
showed identical or similar PFGE patterns were identified. The similarly sized plasmids
carried by the susceptible and resistant strains, the latter containing the carbapenemase
genes, were sequenced and analyzed.
Results: Paired strains were identified from four patients: three had neurosurgical
conditions while the other had acute exacerbation of COPD. Two pairs of Klebsiella
pneumoniae (KP1-S/R and KP2-S/R, S and R indicating susceptible and resistant
strains, respectively), one pair of Morganella morganii (MM-S/R) and one pair of
Enterobacter aerogenes (EA-S/R) were collected. All four carbapenem-resistant strains
carried plasmids harboring blaKPC−2. Compared with the similarly sized plasmids in
KP1-S and KP2-S, an insertion sequence that includes ISKpn6-like, blaKPC−2 and
ISKpn8 was noted in pKP1-R and pKP2-R. Strains MM-R and EA-R had blaKPC−2-
carrying plasmids not resembling plasmids in strains MM-S and EA-S suggesting their
new acquisition while on therapy.
Conclusions: Enterobacteriaceae can acquire carbapenem resistance during
antimicrobial therapy through horizontal transfer of an insertion sequence or plasmid.
Keywords: Enterobacteriaceae, carbapenem resistance, insertion sequence, plasmid, KPC-2
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INTRODUCTION
Carbapenems are the most effective antibiotics for the treatment
of refractory Gram-negative bacterial infections. And yet,
carbapenem-resistant Enterobacteriaceae (CRE) are increasingly
isolated from clinical samples globally (Nordmann et al., 2012).
According to the CHINET (a national antimicrobial resistance
surveillance project in China), the rates of carbapenem-resistant
K. pneumoniae was 2.4% in 2005 and increased to approximately
13.4% in 2014 (Hu et al., 2016). The treatment options for
CRE are limited and these infections are associated with poor
clinical outcome (Schwaber et al., 2008). Understanding how
CRE spreads is crucial for timely implementation of infection
control measures.
The most common mechanism of carbapenem resistance
in Enterobacteriaceae is the production of plasmid-
mediated carbapenemases, and KPCs (Klebsiella pneumoniae
carbapenemases) is currently the most prevalent in many
countries including China (Tzouvelekis et al., 2012). Horizontal
transfer through transposons and integrons may account for the
dissemination of carbapenemase genes carried by CRE strains
(Munoz-Price and Quinn, 2009). Interspecies transfer of the gene
encoding carbapenemase OXA-48 has been demonstrated in the
gut using animal models, suggesting that horizontal transfer of
carbapenemase genes may be an important mode of spread of
CRE (Göttig et al., 2015).
Previously, we have reported the transfer of NDM-1 gene
in E. coli in a patient: a clonally related carbapenem-resistant
E. coli strain was isolated 1 month later after the isolation of
a carbapenem-susceptible E. coli (Ding et al., 2015). A similar
observation has also been made with K. pneumoniae in a patient
with pneumonia (Elliott et al., 2006). It is also reported that, in
some patients with Gram-negative bacterial infections, bacterial
strains belonging to same species from the same anatomical site
might lose susceptibility to the agents that are being used for
treatment (Lee et al., 2011; Solé et al., 2015).
Numerous studies have addressed epidemiology, risk factors
and treatment outcome of CRE infections (Tzouvelekis et al.,
2012), but relatively little attention has been paid to the genetic
process of conversion from carbapenem-susceptible to resistant
of a bacterial strain. In this study, we retrospectively surveyed the
clinical microbiology data of Enterobacteriaceae isolates and the
clinical data of patients in a tertiary hospital in Shanghai, China
from January 2011 to December 2012. As a result, four patients
who had Enterobacteriaceae strains with identical or similar
PFGE patterns and conversion of carbapenem susceptibility
from susceptible to resistant during antimicrobial therapy were
identified. We revealed that horizontal transfer of an insertion
sequence or plasmid carrying blaKPC−2 was responsible for the
in vivo development of carbapenem resistance.
METHODS
Patients
The study was conducted at HuashanHospital, FudanUniversity,
a 1300-bed tertiary care hospital in Shanghai, China. The clinical
microbiology data of Enterobacteriaceae strains from inpatients
between January 2011 and December 2012 were retrospectively
reviewed. Two or more strains of identical or similar species
isolated from the same anatomical site of a patient were
collected if their carbapenem susceptibility converted from
susceptible to resistant during antimicrobial therapy. Isolates
from the same patients with identical or similar PFGE patterns
were then further studied. The clinical data were collected,
including general demographics, such as age and sex; the
ward to which the patient was assigned after admission;
previous use of antimicrobial agents, particularly carbapenems,
extended spectrum cephalosporins and fluoroquinolones.
This study was approved by the Institutional Review Board
of Huashan Hospital and was exempted for obtaining written
informed consents from patients (number: KY2014-233).
Patient records were anonymized and de-identified prior to
analysis.
Clinical Strains and Susceptibility Testing
All the strains were identified by the Vitek 2 automated
system (BioMerieux, France). Antimicrobial susceptibility testing
was performed by the agar dilution method as recommended
by the Clinical and Laboratory Standards Institute (CLSI,
2014). Isolates with nonsusceptibility to either of the two
carbapenems (imipenem and meropenem) tested were classified
as carbapenem-resistant.
Carbapenemase Phenotypic Detection
Modified Hodge Test (MHT) was used for carbapenemase
detection, and the positive result has a clover leaf-like
indentation of the E. coli 25922 growing along the test organism
growth streak within the disk diffusion zone. The phenotypic
detection of carbapenemase was also evaluated with boronic
acid disk tests, the test was considered positive for class A
carbapenemase production when the diameter of the growth-
inhibitory zone around imipenem disk with boronic acid was
≥5mm larger than that around a disk containing imipenem
alone.
PFGE Analysis
PFGEwas employed to determine the genetic relationship among
the clinical isolates of the same species from the same patients.
Genomic DNA was digested with XbaI for 4 h at 37◦C. The
digested DNAs were then separated in 1% agarose gel using a
CHEF-DRIII system (Bio-Rad Laboratories), with a linear pulse
time ramped from 2 to 70 s for 24 h at 14◦C and constant voltage
of 6 V/cm. Similarity between PFGE patterns was determined
according to the criteria proposed by Tenover et al. and with
Bionumerics software using the Dice coefficient. Strains sharing
the restriction patterns of less than or equal to three-band
differences (Tenover et al., 1995) and similarity coefficients>80%
were considered to be closely related strain type (Harris et al.,
2007; Wu et al., 2014).
PCR Detection of β-Lactamase Genes
PCR detection of β-lactamase genes encoding carbapenemases
(blaAIM, blaBIC, blaGIM, blaIMP, blaKPC, blaNDM, blaOXA−48,
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blaSIM,blaSPM, and blaVIM) (Poirel et al., 2011), extended-
spectrum β-lactamases (blaCTX−M) (Woodford et al., 2006),
plasmid-mediated AmpC β-lactamase (blaACC, blaCIT,
blaDHA, blaEBC, blaFOX, and blaMOX) (Pérez-Pérez and
Hanson, 2002) was performed as previously described.
PCR amplicons were sequenced and compared with
sequences available in the GenBank database using BLAST
searches.
Plasmid Analysis
Plasmid DNA was extracted using a Plasmid Midi Kit (QIAGEN,
Germany) according to the manufacturer’s instructions. The
DNA was electrophoresed in 0.8% agarose for 1.5 h. Three
reference strains carrying different sizes of plasmids, with several
plasmids in E. coli V517 (size, 54, 5.6, 5.1, 3.9, 3.0, 2.7,
and 2.1 kb), R1 (92 kb) in E. coli J53 and R27 (182 kb) in
E. coli J53. The plasmids of clinical strains were introduced by
electroporation into E. coli DH10B using a Gene Pulser II system
(Bio-Rad Laboratories). Putative transformants were selected
through PCR screening for blaKPC from the colonies growing on
Mueller-Hinton agar plates containing ampicillin (50 µg/mL).
Transformants harboring a single plasmid with blaKPC were
selected. For carbapenem susceptible strains, transformants with
plasmids of similar sizes with the corresponding blaKPC-positive
plasmids were selected for further investigation. PCR-based
replicon typing (Carattoli et al., 2005) was performed on the
plasmid of these transformants. Each plasmid was then subjected
to EcoRI digestion for 2 h at 37◦C and electrophoresed on a 0.8%
agarose gel for 1.5 h.
Southern blot analysis was performed with DIG High Prime
DNA Labeling and Detection Starter Kit II (F. Hoffmann-
La Roche Ltd., Basel, Swiss). Plasmids were separated on a
0.8% agarose gel and transferred to a nylon membrane as
described previously (Southern, 1975). The probe for blaKPC−2
was amplified using KPC-Fm/KPC-Rm primers (Poirel et al.,
2011) using KP1-R as a template. Following gel-purification, the
800-bp product was randomly primed with DIG-11-dUTP using
the DIG-High Prime DNA Labeling and Detection Starter Kit II.
High-Throughput Sequencing
Plasmid DNA concentration was assessed using Qubit 2.0
Fluorometer (Life Technologies, Carlsbad, CA, USA). Ten
nanograms of DNA was employed to prepare barcoded libraries
with the Ion Plus Fragment Library kit (Life Technologies).
Template preparation and enrichment was performed with
the Ion OneTouchTM 2 System (Life Technologies). Finally,
sequencing was carried out using Ion 318TM chips on the
Ion PGM System (PGMTM, Life Technologies) and with the
Ion PGMTM Sequencing 400 kit. Sequence gaps were filled
by PCR and sequenced using primer walking. Lasergene
sequence analysis software system was used to align the
sequence.
Nucleotide Sequence Accession Numbers
The annotated sequences of pKP1-S, pKP1-R, pKP2-S, and
pKP2-R have been submitted to GenBank nucleotide sequence
database under accession numbers KT922275, KT922274,
KT922273, and KT922272, respectively.
RESULTS
Clinical Cases
From January 2011 to December 2012, four pairs of
Enterobacteriaceae from four patients with identical species,
identical or similar PFGE patterns and discordant carbapenem
susceptibility were identified. Of these four patients, two had a
pair of K. pneumoniae, one a pair ofM. morganii and the other a
pair of E. aerogenes (Table 1).
Patient 1. A 61-year-old male with cerebral hemorrhage
presented to the emergency department in March 2011. After
hematoma cleaning, he developed catheter-associated urinary
tract infection. The patient was empirically treated with
intravenous cefuroxime for 2 weeks with resolution of fever, then
switched to oral cefradine. Urine culture on hospital day 6 grew
carbapenem-susceptible K. pneumoniae (KP1-S). Carbapenem-
resistant K. pneumoniae (KP1-R) was isolated from the urine on
day 30. No other multidrug-resistant isolates were isolated after
this.
Patient 2. A 63-year-old male was hospitalized with
meningioma inOctober 2010. After resection ofmeningioma and
placement of tracheostomy, he was diagnosed with esophageal
injury and possible tracheoesophageal fistula. He had pneumonia
1 month later, and carbapenem-susceptible Pseudomonas
aeruginosa and MDR Acinetobacter baumannii were isolated
from sputum. The patient was treated with ceftazidime, amikacin
and cefoperazone-sulbactam. Seven and half months later,
carbapenem-susceptible K. pneumoniae (KP2-S) was isolated
from the sputum, then he received ceftazidime and levofloxacin.
One week after the therapy, carbapenem-resistantK. pneumoniae
(KP2-R) grew from the sputum.
Patient 3. A 96-year-old male was admitted to the ICU in
March 2011 because of acute exacerbation of chronic obstructive
pulmonary disease (COPD). He had been colonized with
multiple MDR organisms in the respiratory tract, including
carbapenem-resistant P. aeruginosa and carbapenem-resistant
K. pneumoniae. A carbapenem-susceptibleM. morganii (MM-S)
was isolated from the sputum a month later. Hospital-acquired
pneumonia was presumed and treated with meropenem for 2
months. Four months after admission, a carbapenem-resistant
M. morganii (MM-R) was detected in the sputum.
Patient 4. A 52-year-old male was admitted after sustaining
craniocerebral injuries from a fall in November 2012. He required
evacuation of intracranial hematoma and decompressive
craniotomy. Five days after admission, a carbapenem-susceptible
E. aerogenes (EA-S) was isolated from the sputum. During the
first 2 weeks of hospitalization, a variety of MDR organisms
were isolated, including MDR A. baumannii (respiratory
tract), carbapenem-resistant P. aeruginosa (respiratory tract)
and carbapenem-resistant K. pneumoniae (blood). He had
intermittent fever during hospitalization. The patient was treated
with tigecycline and cefoperazone-sulbactam. Seventeen days
after admission, a carbapenem-resistant E. aerogenes (EA-R)
strain was isolated from the sputum.
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Characterization of Clinical Strains
Antimicrobial susceptibility testing revealed that strains KP1-R,
KP2-R, MM-R, EA-R were carbapenem-non-susceptible with
imipenem MICs of 8, 32, 2, and 16 mg/L, respectively (Table 1).
The modified Hodge test was positive for carbapenemase
production and synergy between boronic acid and imipenem was
observed, suggesting the presence of KPC carbapenemase. The
blaKPC−2 gene was detected by PCR in all the four carbapenem
non-susceptible strains. No other carbapenemase genes were
detected (Table 2).
Three pairs of Enterobacteriaceae (KP2-S and KP2-R, MM-S
and MM-R, EA-S, and EA-R) showed identical PFGE patterns,
suggesting that the two strains from each patient belonged to
the same clone. The pair of K. pneumoniae 1 (KP1-S and KP1-R)
strains had >90% similarity of PFGE profiles, indicating they
were highly related (Figure 1). Plasmid DNA analysis revealed
that similar plasmid profiles were found for the pairs of
K. pneumoniae isolates (KP1-S and KP1-R, KP2-S, and KP2-R).
The plasmid profile was identical between E. aerogenes strains
EA-S and EA-R except that EA-R had one extra plasmid. Similarly
sized plasmids also existed in M. morganii strains MM-S and
MM-R (Supplementary Figure 1). Southern blot revealed that
blaKPC−2 was located on plasmids in all four carbapenem-
non-susceptible strains (KP1-R, KP2-R, MM-R, and EA-R)
(Supplementary Figure 1).
Comparison of Plasmids between
Carbapenem-Resistant and -Susceptible
Strains
In order to compare the plasmids harboring blaKPC−2 in
carbapenem-resistant isolates, they were isolated through
electroporation experiment and designated pKP1-S, pKP1-R,
pKP2-S, pKP2-R, pMM-S, pMM-R, and pEA-R.
The screening of β-lactamase genes revealed that the pair
of plasmids pKP1-S and pKP1-R, shared the same resistance
genes blaTEM−1 and blaCTX−M−9, except that blaKPC−2 was
detected in pKP1-R. pKP2-S harbored blaTEM−1 and blaSHV−11,
while blaKPC−2, blaTEM−1, and blaSHV−11 were carried by
pKP2-R. pMM-S harbored blaTEM−1 and blaCTX−M−9, while
only blaKPC−2 was detected by pMM-R. blaKPC−2 was detected
in pEA-R. (Table 2).
Plasmids from two pairs of transformants (pKP1-S and
pKP1-R; pKP2-S and pKP2-R) yielded similar EcoRI digestion
patterns. EcoRI digestion patterns of pMM-S and pMM-R were
inconsistent (Supplementary Figure 1, Table 2).
Sequence Analysis
Three pairs of plasmids (pKP1-S, pKP1-R, pKP2-S, pKP2-R,
pMM-S, and pMM-R) were sequenced to reveal the critical
processes involved in the acquisition of carbapenemases. The
preliminary replicon types of plasmids were determined with the
replicon-specific primers, but pMM-R and pEA-R could not be
typed. Thus, these six plasmids were further typed with sequence
alignment based on the plasmid sequencing data.
IncFIIk replicon was detected in plasmid pKP1-S and pKP1-R.
The skeleton of plasmid pKP1-R was similar with that of pKP1-S.
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TABLE 2 | Comparison of KPC-2 plasmid and plasmid from corresponding carbapenem-susceptible strain and of minimal inhibitory concentration of
transformants.
Transformantsa KP1-S KP1-R KP2-S KP2-R MM-S MM-R EA-R
Plasmid pKP1-S pKP1-R pKP2-S pKP2-R pMM-S pMM-R pEA-R
Plasmid size (approximately kb) ≈140 ≈140 ≈170 ≈170 ≈170 ≈150 ≈40
Inc group IncFIIk IncFIIk IncFII; IncR IncFII; IncR IncA/C2 IncFII; IncN Non-typable
β-lactamase genes in plasmid TEM-1; KPC-2 TEM-1; TEM-1; KPC-2 TEM-1; TEM-1; KPC-2 KPC-2
CTX-M-9 CTX-M-9; SHV-11; SHV-11; CTX-M-9
Minimum inhibitory concentrations (µg/ml)
Imipenem ≤0.06 0.125 ≤0.06 0.25 ≤0.06 1 0.5
Ertapenem ≤0.06 0.25 ≤0.06 0.25 ≤0.06 2 0.5
Piperacillin/tazobactam 4 64 2 64 4 >128 >128
Ceftazidime 2 4 32 32 1 32 >128
Amikacin 1 1 >128 >128 4 2 1
Levofloxacin ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06
aKP, Klebsiella pneumoniae; MM, Morganella morganii; EA, Enterobacter aerogenes.
FIGURE 1 | Dendrogram of XbaI-digested genomic DNA of clinical isolates. The dendrogram was constructed using BioNumerics software version 6.6
(Applied Maths, St-Martens-Latem, Belgium). KP, Klebsiella pneumoniae; MM, Morganella morganii; EA, Enterobacter aerogenes.
A 2.6 kb scaffold in pKP1-S was not present in pKP1-R, while
two scaffolds about 2.3 and 2.4 kb in pKP1-R were not found
in pKP1-S. Plasmid pKP1-R was very similar to two blaKPC−2-
carrying plasmids, pKP048 (GenBank accession no. FJ628167.2)
and pKPC-LK30 (GenBank accession no. KC405622.1). Analysis
on an 11,954-bp scaffold carrying blaKPC−2 gene in pKP1-R
(it is about 6 kb larger than the corresponding scaffold in
pKP1-S, GenBank accession no. KT922274), we found that a
6625-bp DNA fragment inserted at the upstream end of tnpA
had taken place on pKP1-S (GenBank accession no. KT922275).
The blaKPC−2 gene was located on an insertion sequence which
included an ISKpn6-like element followed by blaKPC−2 and
interrupted ISKpn8 (Figure 2).
Both IncFII and IncR replicons were present in pKP2-S
and pKP2-R. The scaffold of plasmid pKP2-R was also similar
with that of pKP2-S. Two fragments about 4.2 and 1.3 kb
in pKP2-S were not present in pKP2-R. Over 80% sequence
of plasmid pKP2-R is identical to pKPC-LK30 (GenBank
accession no. KC405622.1). For pKP2-R, a nucleotide sequence
of 25,428 bp surrounding blaKPC−2 gene was obtained (GenBank
accession no. KT922272). Compared with the scaffold obtained
from pKP2-S (GenBank accession no. KT922273), a DNA
fragment insertion of 6880 bp was found. Like pKP1-R,
the insertion sequence including the ISKpn6-like element,
blaKPC−2 and ISKpn8 was inserted at the upstream end
of tnpR and downstream of IS26 in pKP2-S (Figure 2). A
5819-bp common region in the inserted DNA sequences
from pKP1-R and pKP2-R is identical to Tn1721 that
includes ISKpn6-like, blaKPC−2 and interrupted ISKpn8. The
blaKPC−2 was also carried by the same insertion sequence
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FIGURE 2 | Plasmid structures surrounding blaKPC-2 gene in K. pneumoniae and M. morganii. (A) Comparison between plasmids pKP1-S and pKP1-R. (B)
Comparison between plasmids pKP2-S and pKP2-R. (C) blaKPC−2 and its surrounding genetic elements of plasmid pMM-R. The differences between the plasmids
are shown, and the genes are depicted as arrows according to the direction of transcription. The dots indicated the inserted DNA sequences in pKP1-R and pKP2-R.
The blaKPC−2 genes are shown in black.
including ISKpn6-like, blaKPC−2 and ISKpn8 in plasmid pMM-R
(Figure 2).
IncA/C2 replicon was detected in plasmid pMM-S. A 120-kb
region in pMM-S was similar to pVC1447 (GenBank accession
no: KJ817377), a plasmid originally isolated from Vibrio cholerae.
Both IncFII and IncN replicons were present in pMM-R. Plasmid
pMM-R was 150 kb in length and had a 45-kb region identical
to pKP1034 isolated from K. pneumoniae sequence type 11,
which co-harbored blaKPC−2, fosA3, rmtB and blaCTX−M−65
(GenBank accession no: KP893385). No similar sequence was
found between the scaffold of pMM-R and pMM-S.
DISCUSSION
In this study, we identified four instances where patients were
initially colonized or infected with a blaKPC-negative strain,
which later evolved to acquire blaKPC. These patients shared
in common critical illness and recent receipt of β-lactam
agents. However, only one patient received carbapenem therapy
before the carbapenem-resistant clinical strains were isolated.
As previously reported, underlying medical conditions and
antimicrobial exposure (fluoroquinolones and antipseudomonal
penicillins in particular) are important risk factors for CRE
acquisition (Falagas et al., 2007; Schwaber et al., 2008). This study
also underscores that β-lactam agents other than carbapenems
may also exert selective pressure for acquisition of blaKPC thus
evolution to CRE.
In all four patients studied here, carbapenem resistance was
associated with in vivo acquisition of an insertion sequence
that carries blaKPC−2 or a plasmid harboring blaKPC−2 in
Enterobacteriaceae. Themost prevalent carbapenemase is KPC in
China (Hu et al., 2012). The two pairs ofK. pneumoniae belonged
to ST11 and the four plasmids pKP1/2-R/S from these isolates
were all classified as IncF family. ST11 was previously reported as
the dominant clone in the region (Qi et al., 2011), and IncF family
is the most predominant blaKPC−2-carrying plasmid, which is
particularly well-suited for K. pneumoniae and for sustaining the
presence of blaKPC−2 through multiple independent insertion
and transposition events (Mathers et al., 2015).
Plasmids analysis provides insights into the mechanism of
acquisition of genetic determinants carrying carbapenemase
genes. Sequencing data revealed that pKP1-R and pKP2-R
acquired mobile genetic elements containing blaKPC−2 gene. The
two insertion sequences were parts of Tn1721 as previously
described (Shen et al., 2009). We also found that tnpA was
located upstream of blaKPC−2 in pKP1-R and pKP2-R, suggesting
the transposition might involve mobilization of the insertion
sequence. Interestingly, the insertion sequences, together with
the flanking regions of blaKPC−2 in plasmids pKP1-R and
pKP2-R, are identical with other blaKPC−2 harboring plasmids
pKP048 (Shen et al., 2009) and pKPC-LK30 (Chen et al., 2014),
respectively. This finding suggests that insertion of the blaKPC−2
region into IncF family plasmids is likely to be site-specific.
The differences of scaffolds between pKP1-R and pKP1-S, pKP2-
R and pKP2-S indicate that DNA fragments exchange may
take place. Further studies are still needed to elucidate the
mechanisms of the DNA fragment mobilization. To the best of
our knowledge, this is the first report of insertion of blaKPC−2-
carrying genetic element to plasmids in clinical isolates of
K. pneumoniae in vivo.
The sizes of plasmids pMM-S and pMM-R were similar
but they had different restriction patterns (data not shown).
pMM-S was belonged to plasmid type of IncA/C2, while
pMM-R was IncFII and IncN. Plasmid sequencing data
showed that no similar sequence was observed between the
scaffold of pMM-S and pMM-R. A possible explanation
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is that the carbapenem-susceptible M. morganii acquired a
phylogenetically distinct IncFII and IncN plasmid carrying
blaKPC−2 while lost the IncA/C2 plasmid. The blaKPC−2-
carrying plasmid pMM-R may have been acquired from
another MDR organism that was not cultured. The horizontal
transfer of plasmids containing resistance genes is an essential
mechanism for the dispersion of antimicrobial resistance
(Mathers et al., 2015). Sidjabat et al. (2009) also revealed
that blaKPC−2 was likely transferred in vivo from E. coli to
Serratia marcescens by conjugation of the plasmid harboring
blaKPC−2.
Co-infections with carbapenem-resistant strains of Gram-
negative species are a point of interest in medical microbiology
(Marchaim et al., 2012). All patients except patient 1 had
co-infection or co-colonization with carbapenem-resistant
A. baumannii (patient 2), P. aeruginosa and K. pneumoniae
(patient 3), P. aeruginosa, A. baumannii and K. pneumoniae
(patient 4), respectively. Under antimicrobial selection pressure,
transposition of insertion sequences or movement of plasmid
from these co-infected strains may emerge as responses to
environment changes (Sidjabat et al., 2009). Those co-infecting
carbapenem-resistant strains were investigated to track the
potential sources of blaKPC−2 genetic elements and plasmids.
Clinical strains of K. pneumoniae from patients 3 and 4 in fact
harbored blaKPC−2; however, the sizes of the plasmids harboring
blaKPC−2 were not identical to the plasmids from pMM-R and
pEA-R, respectively (data not shown). Although the source
of plasmids harboring blaKPC−2 could not be identified, we
assume that blaKPC−2 was acquired from the co-infecting or
co-colonizing strains. The mobility of blaKPC−2 genetic elements
may be responsible for the formation of plasmids pMM-R and
pEA-R.
In conclusion, our results suggest that, in addition to
clonal expansion, mobile genetic elements including insertion
sequences and plasmids can play a significant role in the
acquisition of carbapenem resistance in vivo, adding further
complexity to the already complicated molecular epidemiology.
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